There is a possible trend of greater inhibition at lower viral titers, suggesting that Cas13d PAC-MAN could be more effective for prevention of new infections, which typically occur from exposure to a low level of virus.
← all excerpts
Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza.
1
—
—